ENTITY
JD Health International

JD Health International (6618 HK)

365
Analysis
Consumer StaplesChina
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
Refresh
12 Jun 2021 06:59

Asia Shorts: Meituan, JDH, Smoore, Ping An, Kirin, NTT, Toshiba, HMM, Doosan, LGD, Hanwha, Evergreen

The Insight looks at large short interest movements across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
206 Views
Share
bullishKanzhun
07 Jun 2021 18:17

Smartkarma North Asia Weekly: POTUS Order, Kanzhun, Angelalign, & 3 Children Policy in China

In this edition of the Smartkarma North Asia Weekly, it summarizes some of the top insights on Smartkarma in the past week covering Japan, HK...

Logo
250 Views
Share
bullishKanzhun
06 Jun 2021 10:37

ECM Weekly (6th June 2021) - Kanzhun, Full Truck, Aihuishou, Angelalign, Del Monte PH, WM, Renesas

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
03 Jun 2021 11:09

HSI Index Rebalance Preview: Potential Inclusions in September

There could be 8 additions to the HSI at the September review to take the index members up to 66. Turnover will be less than 5% and there are a lot...

Logo
451 Views
Share
03 Jun 2021 09:25

JD Health (京东健康) Lock-Up Expiry -  US$6.6bn Pre-IPO Shares Unlocked, Sitting on 400%+ Gain

JD Health (6618 HK) (JDH) was listed on the Hong Kong Exchange on 8th December, 2020. Its IPO lock-up will expire on 8th June, 2021.

Share
x